Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-3,900
Closed -$20K 5473
2022
Q2
$20K Sell
3,900
-1,500
-28% -$79.6K ﹤0.01% 2683
2022
Q1
$23K Buy
+5,400
New +$279K ﹤0.01% 2941
2018
Q2
Sell
-24,700
Closed -$26K 4828
2018
Q1
$26K Buy
+24,700
New +$1.03M ﹤0.01% 2107
2017
Q2
Sell
-109,100
Closed -$27K 7023
2017
Q1
$27K Buy
109,100
+72,100
+195% +$3.06M ﹤0.01% 3030
2016
Q4
$234K Buy
37,000
+23,500
+174% +$926K 0.01% 1188
2016
Q3
$10K Buy
+13,500
New +$542K ﹤0.01% 4234
2016
Q1
Sell
-1,000
Closed -$7K 7140
2015
Q4
$7K Buy
+1,000
New +$46K ﹤0.01% 4578

Other funds holding SNY

Cutler Group's SNY Position: Q3 2022 in Review

Cutler Group sold out of Sanofi (SNY) in Q3 2022, closing a stake of 3,800 shares — an estimated $169K sold.

Cutler Group first reported a position in SNY in Q4 2015 and held it in 6 quarters. The position peaked at $885K in Q1 2018. 587 funds tracked by Wall St. Rank hold SNY as of Q3 2022.

  • Cutler Group reported no remaining Sanofi position as of Q3 2022 after selling out during the quarter.
  • Cutler Group sold 3,800 Sanofi shares in Q3 2022, an estimated $169K.
  • Cutler Group first reported a position in Sanofi in Q4 2015 and held it in 6 quarters.
  • Cutler Group's Sanofi position peaked at $885K in Q1 2018.
  • 587 funds tracked by Wall St. Rank held Sanofi as of Q3 2022.

Based on Cutler Group's 13F filing for Q3 2022, filed 25 Oct 2022.